tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tandem Diabetes downgraded to Hold from Buy at Lake Street
PremiumThe FlyTandem Diabetes downgraded to Hold from Buy at Lake Street
21d ago
Tandem Diabetes price target lowered to $51 from $53 at Barclays
Premium
The Fly
Tandem Diabetes price target lowered to $51 from $53 at Barclays
25d ago
Positive Outlook for Tandem Diabetes Care: Buy Rating Reaffirmed Amid Growth Catalysts and Strategic Opportunities
Premium
Ratings
Positive Outlook for Tandem Diabetes Care: Buy Rating Reaffirmed Amid Growth Catalysts and Strategic Opportunities
25d ago
Tandem Diabetes announces medical device correction for t:slim X2 insulin pumps
PremiumThe FlyTandem Diabetes announces medical device correction for t:slim X2 insulin pumps
25d ago
Tandem Diabetes downgraded to Hold from Buy at Nephron Research
Premium
The Fly
Tandem Diabetes downgraded to Hold from Buy at Nephron Research
25d ago
Tandem Diabetes price target lowered to $13 from $20 at Wells Fargo
Premium
The Fly
Tandem Diabetes price target lowered to $13 from $20 at Wells Fargo
26d ago
Tandem Diabetes reports Q2 EPS (78c), consensus (40c)
PremiumThe FlyTandem Diabetes reports Q2 EPS (78c), consensus (40c)
26d ago
Tandem Diabetes sees FY25 revenue approximately $1B, consensus $1B
Premium
The Fly
Tandem Diabetes sees FY25 revenue approximately $1B, consensus $1B
26d ago
Notable companies reporting after market close
Premium
The Fly
Notable companies reporting after market close
26d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100